These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6568874)

  • 21. [Increased immunologic reactivity against hepatoma 22A cells in MTV-infected C3H mice in comparison to MTV-free mice].
    Lavrovskiĭ VA; Viksler VKh
    Biull Eksp Biol Med; 1980 Oct; 90(10):467-9. PubMed ID: 6252986
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Tumor-specific cytotoxicity of tumor infiltrating lymphocytes (TIL) induced with TCGF in murine mammary carcinoma].
    Hori T; Kan N; Ohgaki K; Yamazaki N; Nakayama N; Nio Y; Inamoto T
    Nihon Geka Gakkai Zasshi; 1984 Aug; 85(8):749-57. PubMed ID: 6238229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of "eclipsed" lymphoid cells from advanced tumor-bearing mice through adoptive transfer to sublethally irradiated syngeneic hosts.
    Youn JK; Le Francois D; Hue G; Santillana M; Barski G
    Int J Cancer; 1975 Oct; 16(4):629-38. PubMed ID: 1176209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lysis of fresh murine mammary tumor cells by syngeneic natural killer cells and lymphokine-activated killer cells.
    Ames IH; Gates CE; Garcia AM; John PA; Hennig AK; Tomar RH
    Cancer Immunol Immunother; 1987; 25(3):161-8. PubMed ID: 3499983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural cell-mediated cytotoxicity in vitro and inhibition of tumor growth in vivo by murine lymphoid cells cultured with T cell growth factor (TCGF).
    Kedar E; Ikejiri BL; Gorelik E; Herbermann RB
    Cancer Immunol Immunother; 1982; 13(1):14-23. PubMed ID: 6984352
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elimination of tumor-enhancing cells by cyclophosphamide and its relevance to cyclophosphamide therapy of the murine mammary tumor.
    Nakajima H; Abe S; Masuko Y; Tsubouchi J; Yamazaki M; Mizuno D
    Gan; 1981 Oct; 72(5):723-31. PubMed ID: 7327373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of tumor-associated lymphocytes in a series of mouse mammary tumor lines with differing biological properties.
    Rios AM; Miller FR; Heppner GH
    Cancer Immunol Immunother; 1983; 15(2):87-91. PubMed ID: 6553517
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effector and enhancing lymphoid cells in plasmacytoma-bearing mice. II. Dynamic changes during tumor progression.
    Wang WC; Berczi I; Hoffmann EG; Sehon AH
    Int J Cancer; 1980 Apr; 25(4):493-501. PubMed ID: 6246008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of in vitro and in vivo studies of antigens relevant to the control of murine breast cancer.
    Stutman O
    Cancer Res; 1976 Feb; 36(2 pt 2):739-47. PubMed ID: 175934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction in culture between mouse ascites mammary carcinoma (MM2) cells and lymphoid cells of isologous mice.
    Katsuta H; Ashikawa K; Takaoka T
    Jpn J Exp Med; 1975 Jun; 45(3):223-9. PubMed ID: 1177362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bispecific antibodies retarget murine T cell cytotoxicity against syngeneic breast cancer in vitro and in vivo.
    Moreno MB; Titus JA; Cole MS; Tso JY; Le N; Paik CH; Bakács T; Zacharchuk CM; Segal DM; Wunderlich JR
    Cancer Immunol Immunother; 1995 Mar; 40(3):182-90. PubMed ID: 7728777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinct T-cell proliferative responses to 13762A rat mammary adenocarcinoma and derived clones.
    Christensen ND; Kreider JW; Bartlett GL; Horetsky RL
    Cell Immunol; 1986 Feb; 97(2):433-45. PubMed ID: 3091274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor-specific immune responsiveness of the tumor-bearing host.
    Burk MW; Yu S; McKhann CF
    Isr J Med Sci; 1976; 12(4-5):360-8. PubMed ID: 939694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppressor cells in mice with murine mammary tumor virus-induced mammary tumors. I. Inhibition of mitogen-induced lymphocyte stimulation.
    Rudczynski AB; Mortensen RF
    J Natl Cancer Inst; 1978 Jan; 60(1):205-11. PubMed ID: 203703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of lymphoid cells responding to virus- and tumor-associated antigens in spleens of syngeneic mouse mammary tumor systems with low and high oncogenic potentials.
    Lopez DM; Paul RD
    J Natl Cancer Inst; 1982 Dec; 69(6):1403-9. PubMed ID: 6292565
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunologic, virologic, and genetic aspects of mammary tumor virus-induced cell-surface antigens: presence of these antigens and the Thy 1.2 antigen on murine mammary gland and tumor cells.
    Hilgers J; Haverman J; Nusse R; van Blitterswijk WJ; Cleton FJ; Hageman PC; van Nie P; Calafat J
    J Natl Cancer Inst; 1975 Jun; 54(6):1323-33. PubMed ID: 166186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic administration of recombinant interleukin 2 stimulates in vivo lymphoid cell proliferation in tissues.
    Ettinghausen SE; Lipford EH; Mulé JJ; Rosenberg SA
    J Immunol; 1985 Aug; 135(2):1488-97. PubMed ID: 3891854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells.
    Allavena P; Introna M; Sessa C; Mangioni C; Mantovani A
    J Natl Cancer Inst; 1982 Apr; 68(4):555-62. PubMed ID: 6175786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specific killing of tumor cells in vitro in the presence of normal lymphoid cells and sera from hosts immune to the tumor antigens.
    Pollack S; Heppner G; Brawn RJ; Nelson K
    Int J Cancer; 1972 Mar; 9(2):316-23. PubMed ID: 5041610
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.